Please ensure Javascript is enabled for purposes of website accessibility

CVS Caremark vs. Walgreen

By Claire Stephanic – Updated Apr 6, 2017 at 1:02PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The two go head-to-head in competition for pharmacy customers.

CVS Caremark (NYSE: CVS) and Walgreen (NYSE: WAG) are longtime competitors -- both Fortune 500 companies in the pharmacy services/retail drug store business -- and according to a recent CNN article, the feud has intensified. Both companies run pharmacy benefit management (PBM) plans with several million members. CVS Caremark dropped Walgreen from its PBM in reaction to Walgreen's announcement on Monday that it would no longer participate in new or renewed plans from CVS Caremark's drug benefits unit.

CVS Caremark's move is clearly a direct attempt to compete for Walgreen's customers. It means that some CVS Caremark plan members may not have their prescriptions honored at a Walgreens pharmacy, and consequently, may be forced to pay much more at Walgreens. Walgreen, of course, is not pleased, and its spokesperson said: "Right now, you may be 2 miles from a Walgreens, but because of this action, you may have to drive 20 miles to another pharmacy to get prescriptions filled."

CVS Caremark maintains that, excluding Walgreen, its pharmacy network includes about 57,000 pharmacies across the country (including other retail chains, supermarket pharmacies, and independent pharmacies), while Walgreen operates 7,500 stores nationwide. However, Walgreen has more than 50% market share in certain cities, and industry consultant Adam Fein said, "Personally I think that CVS Caremark is making a major strategic blunder. I don't think they can assemble a credible pharmacy network in certain cities without Walgreens."

What do you think? Blunder or brilliant move? Let us know in the comments box below.

Claire Stephanic does not own any of the companies mentioned. You can read The Motley Fool's disclosure policy here.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$32.69 (-0.43%) $0.14
CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$97.74 (-0.62%) $0.61

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.